Skip to main content

Table 6 Number of subjects who rated as Good, Neutral or Poor in terms of CVD risk reduction, from Day 0 to Day 28

From: A randomized clinical trial to determine the efficacy of manufacturers’ recommended doses of omega-3 fatty acids from different sources in facilitating cardiovascular disease risk reduction

Type of FA

Score

OS™(EPA + DPA + DHA)

ω-3 SES

E + DSES

ω-3 RBCES

Total

Total minus E + DSES

rTG

Good

26

26

9

27

88

79

Concentrated

Neutral

6

6

23

5

40

17

Triglyceride

Poor

0

0

0

0

0

0

EE

Good

19

23

10

16

68

58

Ethyl ester

Neutral

12

6

21

15

54

33

 

Poor

1

3

1

1

6

5

PL

Good

14

12

7

10

43

36

Phospho-

Neutral

15

14

23

19

71

48

lipid (krill)

Poor

3

6

2

3

14

12

TG

Good

18

12

7

9

46

39

Triglyceride

Neutral

10

15

25

21

71

46

 

Poor

4

5

0

2

11

11

  1. OS™: OmegaScore™; ω-3 SES: Omega-3 Serum Equivalence Score; E + DSES: EPA + DHA Serum Equivalence Score; ω-3 RBCES: Omega-3 Red Blood Cell Equivalence Score (Omega-3 Index).
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X